G
GRAIL
Developing blood tests for early cancer detection high-intensity sequencing, population-scale clinical trials, and state of the art Computer Science and Data Science
At a glance
- Status
- Listed
Knowledge graph
Market map
Rare Disease Therapeutics & Technologies Landscape
Market map
1k+ Global Genetics & Genomics startups
Unicorn list
Biotech & Life Sciences unicorns
Unicorn list
Unicorns in United States
Open roles
GRAIL in the Menlo Park ecosystem
The GRAIL office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A6 investors entered at this stage
Sutter Hill Ventures
Bezos Expeditions
GV
Illumina
ARCH Venture Partners- BGBill Gates
Series B and later12 investors entered at this stage
Sequoia- GSGenuity Science
- 6C6 Dimensions Capital
Hillhouse Capital- CIChina Merchant Securities International
- HCHuangPu River Capital
CPP Investments- AGAlly Bridge Group
- ICIndustrial and Commercial Bank of China
- BCBlue Pool Capital
- JJJohnson & Johnson
- CICRF Investment
Source: Dealroom Talent Intelligence.
Alumni founders
Former GRAIL employees who went on to found companies, sorted by Dealroom signal score.
CECellanomeEst. 2020
ANAria NetworksEst. 2025
Subhachandra ChandraUnited States
XTXaira TherapeuticsEst. 2023
Vik BajajUnited States
BABeacons AIEst. 2019
Jesse ZhangUnited StatesPatents
181 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See GRAIL on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
FDA advisory panel backs GRAIL's Galleri multi-cancer blood test